Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
SAYBMrZwZVVHYTrH